Heart to Heart with Dr Michelle O'Donoghue

 
 
  • ACC 2022 Making Healthy (Plant-Based) Diets the Easy Choice   Drs Michelle O'Donoghue and Robert Ostfeld discuss plant-based nutrition and how to make it easier for us to choose healthy foods to improve our cardiovascular health.
  • ACC 2022 SuperWIN: Supermarket Partnership Improves DASH Diet Score   In a novel trial, DASH diet scores improved after participants were taught how to shop for healthier food, whether online or instore. Investigator Dylan Steen shares the details.
  • AHA 2021 Surgical Consult From AHA: Act Earlier in AS and TR?   Michelle O'Donoghue and Patrick O'Gara discuss early surgery in asymptomatic AS and concomitant TR repair in patients undergoing mitral valve surgery. Should either trial change practice?
  • ESC 2021 Is 1-Month DAPT Safe? Reconciling MASTER DAPT and STOPDAPT-2   Drs O'Donoghue and Valgimigli discuss abbreviated dual antiplatelet therapy data in high bleeding risk and acute coronary syndrome from studies presented at the 2021 European Society of Cardiology Congress.
  • ACC 2021 Does ADAPTABLE Inform Aspirin Dosing for Secondary Prevention?   Patient engagement, social media, and the internet all contributed to the unique design of the ADAPTABLE trial, but did it answer the question on the best dose of aspirin to use?
  • New Physician Moms Need More Resources and Less Guilt   Returning to practice after maternity leave prompted Michelle O'Donoghue to advocate for new moms in the healthcare workplace.
  • No Obstruction Shouldn't Mean No Diagnosis: HARP-MINOCA   A new study finds that multimodal imaging can reveal the cause of most MINOCA. Lead investigator Harmony Reynolds shares the details from her AHA presentation with Michelle O'Donoghue.
  • When It's Assumed That You're the Cleaner, Not a Cardiologist   Backstage at a cardiology conference, Michelle O'Donoghue was handed the dirty coffee mugs; the AV tech assumed she was the cleaner and not one of the late-breaking trial discussants.
  • No Shame in Choosing Not to Be a COVID-19 Hero   A revealing FaceTime call with her mother, a fellow cardiologist, caused Lisa Rosenbaum to change course during the COVID-19 surge. The NEJM columnist discusses her reasoning with Michelle O'Donoghue.
  • What Does VOYAGER PAD Mean for Antithrombotic Therapy?   What are the practice implications of the study that compared low-dose rivaroxaban plus aspirin vs rivaroxaban alone? How does it differ from COMPASS? Michelle O'Donoghue gets answers from the PI.
  • Dropping Aspirin Post PCI: Are We There Yet?   Is P2Y12 inhibitor monotherapy post PCI ready to go mainstream? Michelle O'Donoghue considers the question of when to drop aspirin in the context of recent trials on antiplatelet therapy.
  • Why This Cardiologist Trained in Critical Care Medicine   Michelle O'Donoghue and Erin Bohula discuss issues in critical care cardiology, such as challenges for trainees and the need for more research to strengthen the lacking evidence base.
  • Women as One: 'The Sky's the Limit' for Women in Medicine   Roxana Mehran, MD, co-founder of Women as One, explains its mission to coach and mentor female physicians to develop leadership skills, learn negotiation tactics, and maximize their talents.
  • Apple Watch ECG: Helpful or Headache?   The new ECG feature on the Apple Watch has Michelle O'Donoghue, MD, wondering whether technology is outpacing our ability to interpret and analyze resulting data.
  • Requiem for Aspirin in Dual Antiplatelet Therapy?   Mounting evidence makes Dr Michelle O'Donoghue wonder whether the perennial question on the optimal duration of DAPT should be revised to: How soon can you drop the aspirin? Have you changed your practice?
  • Does (S)He Who Tweets Loudest Rule?   Michelle O'Donoghue, a slow adopter of social media, likes that it can provide a voice to all but worries that a vocal few dominate the conversation.
  • Plant-Based Diets as Medicine: Food for Thought   Best-selling author Caldwell Esselstyn and former ACC president Kim Williams discuss their embrace of a plant-based diet and what it will take for the medical profession to take nutrition seriously.
  • What Cardiologists Need to Know About New Diabetes Drugs   Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.
  • What COMPASS and RE-DUAL Mean for Aspirin and Triple Therapy   Drs Cohen and O'Donoghue review new data from the COMPASS and RE-DUAL PCI trials and potential strategies for patients who need anticoagulation and antiplatelet therapy.
  • PURE Confusion: Observational Data Can't Tell Us What to Eat   The PURE study suggests that dietary saturated fat is good and carbohydrates bad, but nutritional guidelines should be based purely on randomized data, argues Dr O'Donoghue.